These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 18165206)
1. Caregiver preferences for pediatric asthma treatment delivery systems. Hitchcock W; Mellon M; Memran M; Parasuraman B; Ramachandran S; Walzer S Adv Ther; 2007; 24(6):1240-53. PubMed ID: 18165206 [TBL] [Abstract][Full Text] [Related]
2. Effects of budesonide inhalation suspension compared with cromolyn sodium nebulizer solution on health status and caregiver quality of life in childhood asthma. Murphy KR; Fitzpatrick S; Cruz-Rivera M; Miller CJ; Parasuraman B Pediatrics; 2003 Sep; 112(3 Pt 1):e212-9. PubMed ID: 12949315 [TBL] [Abstract][Full Text] [Related]
3. Factors associated with adolescent and caregiver reported problems in using asthma medications. Sleath B; Carpenter DM; Walsh KE; Davis SA; Hayes Watson C; Lee C; Loughlin CE; Garcia N; Reuland DS; Tudor G J Asthma; 2019 Apr; 56(4):451-457. PubMed ID: 29668340 [TBL] [Abstract][Full Text] [Related]
4. Children with asthma and their caregivers help improve written asthma action plans: A pilot mixed-method study. Gillette C; Rockich-Winston N; Shepherd M; Flesher S J Asthma; 2018 Jun; 55(6):609-614. PubMed ID: 28759273 [TBL] [Abstract][Full Text] [Related]
5. Medication use, sleep, and caregiver smoking status among urban children with asthma. Miadich SA; Everhart RS; Heron KE; Cobb CO J Asthma; 2018 Jun; 55(6):588-595. PubMed ID: 28759271 [TBL] [Abstract][Full Text] [Related]
6. Adherence to inhaled corticosteroids: comparison of available therapies. Murphy KR Pulm Pharmacol Ther; 2010 Oct; 23(5):384-8. PubMed ID: 20542129 [TBL] [Abstract][Full Text] [Related]
7. Caregiver-physician medication concordance and undertreatment of asthma among inner-city children. Riekert KA; Butz AM; Eggleston PA; Huss K; Winkelstein M; Rand CS Pediatrics; 2003 Mar; 111(3):e214-20. PubMed ID: 12612274 [TBL] [Abstract][Full Text] [Related]
8. Child- and caregiver-reported problems and concerns in using asthma medications. Sleath B; Ayala GX; Davis S; Williams D; Tudor G; Yeatts K; Washington D; Gillette C J Asthma; 2010 Aug; 47(6):633-8. PubMed ID: 20632916 [TBL] [Abstract][Full Text] [Related]
9. Family caregivers' reported nonadherence to the controller medication of asthma in children in Casablanca (Morocco): Extent and associated factors. Ménard S; Jbilou J; Lauzier S J Asthma; 2018 Dec; 55(12):1362-1372. PubMed ID: 29336706 [TBL] [Abstract][Full Text] [Related]
10. Asthma treatment preference study: a conjoint analysis of preferred drug treatments. Johansson G; Ställberg B; Tornling G; Andersson S; Karlsson GS; Fält K; Berggren F Chest; 2004 Mar; 125(3):916-23. PubMed ID: 15006950 [TBL] [Abstract][Full Text] [Related]
11. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366 [TBL] [Abstract][Full Text] [Related]
12. Paediatric pulmonary drug delivery: considerations in asthma treatment. Berger WE Expert Opin Drug Deliv; 2005 Nov; 2(6):965-80. PubMed ID: 16296802 [TBL] [Abstract][Full Text] [Related]
13. Factors affecting primary care provider and caregiver concordance for pediatric asthma medications. Butz A; Sellers MD; Land C; Walker J; Tsoukleris M; Bollinger ME J Asthma; 2009 Apr; 46(3):308-13. PubMed ID: 19373641 [TBL] [Abstract][Full Text] [Related]
14. Selective provision of asthma self-management tools to families. Cabana MD; Chaffin DC; Jarlsberg LG; Thyne SM; Clark NM Pediatrics; 2008 Apr; 121(4):e900-5. PubMed ID: 18381518 [TBL] [Abstract][Full Text] [Related]
15. The impact of expired and empty quick-relief asthma inhalers: The Asthma and Allergy Foundation of America's Asthma Inhaler Design Survey. Storms WW; Tringale M; Ferro TJ Allergy Asthma Proc; 2015; 36(4):300-5. PubMed ID: 25916212 [TBL] [Abstract][Full Text] [Related]
16. Developing therapeutics for the treatment of pediatric asthma. Eskandar F; Fleming S Curr Opin Investig Drugs; 2010 May; 11(5):550-8. PubMed ID: 20419601 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of MDI-spacer utilization and technique in caregivers of urban minority children with persistent asthma. Reznik M; Silver EJ; Cao Y J Asthma; 2014 Mar; 51(2):149-54. PubMed ID: 24131031 [TBL] [Abstract][Full Text] [Related]
18. [Inhaled antiasthmatics in children. How to choose?]. Fleurence E; de Blic J Arch Pediatr; 2000 Mar; 7(3):297-301. PubMed ID: 10761609 [TBL] [Abstract][Full Text] [Related]
19. A community-engaged approach to quantifying caregiver preferences for the benefits and risks of emerging therapies for Duchenne muscular dystrophy. Peay HL; Hollin I; Fischer R; Bridges JF Clin Ther; 2014 May; 36(5):624-37. PubMed ID: 24852596 [TBL] [Abstract][Full Text] [Related]
20. Clinical use of nebulized budesonide inhalation suspension in a child with asthma. Skoner DP; Angelini BL; Friday G; Gentile D J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 2):210-4. PubMed ID: 10518848 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]